291 related articles for article (PubMed ID: 15522921)
1. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
2. [Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain].
Camps García MT; Ocón Sánchez P; Alonso Ortiz A; Belmonte López MA; García Portales R; Frutos Sanz MA; Guil García M; de Ramón Garrido E
Med Clin (Barc); 1994 May; 102(18):688-93. PubMed ID: 8028418
[TBL] [Abstract][Full Text] [Related]
3. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.
Wilson AG; Gordon C; di Giovine FS; de Vries N; van de Putte LB; Emery P; Duff GW
Eur J Immunol; 1994 Jan; 24(1):191-5. PubMed ID: 8020556
[TBL] [Abstract][Full Text] [Related]
4. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
Skarsvåg S; Hansen KE; Holst A; Moen T
Tissue Antigens; 1992 Sep; 40(3):128-33. PubMed ID: 1440567
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.
Hartung K; Baur MP; Coldewey R; Fricke M; Kalden JR; Lakomek HJ; Peter HH; Schendel D; Schneider PM; Seuchter SA
J Clin Invest; 1992 Oct; 90(4):1346-51. PubMed ID: 1401069
[TBL] [Abstract][Full Text] [Related]
6. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
7. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
[TBL] [Abstract][Full Text] [Related]
8. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Bishof NA; Welch TR; Beischel LS; Carson D; Donnelly PA
Pediatr Nephrol; 1993 Jun; 7(3):243-6. PubMed ID: 8100139
[TBL] [Abstract][Full Text] [Related]
9. [HLA markers and complotypes: risk factors in systemic lupus erythematosus?].
Gougerot A; Stoppa-Lyonnet D; Poirier JC; Schmid M; Busson M; Marcelli A
Ann Dermatol Venereol; 1987; 114(3):329-34. PubMed ID: 3605963
[TBL] [Abstract][Full Text] [Related]
10. [Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].
Specker C; Lakomek HJ; Kuntz BM; Bremer G; Goerz G; Krüskemper HL
Dtsch Med Wochenschr; 1987 Apr; 112(15):577-80. PubMed ID: 3493893
[TBL] [Abstract][Full Text] [Related]
11. Molecular mapping of the HLA class II region in HLA-DR3 associated idiopathic membranous nephropathy.
Sacks SH; Warner C; Campbell RD; Dunham I
Kidney Int Suppl; 1993 Jan; 39():S13-9. PubMed ID: 8096882
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members.
Yao Z; Kimura A; Hartung K; Haas PJ; Volgger A; Brünnler G; Bönisch J; Albert ED
Immunogenetics; 1993; 38(6):421-9. PubMed ID: 8406614
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes.
Bettinotti MP; Hartung K; Deicher H; Messer G; Keller E; Weiss EH; Albert ED
Immunogenetics; 1993; 37(6):449-54. PubMed ID: 8436420
[TBL] [Abstract][Full Text] [Related]
14. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
15. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex extended haplotypes in systemic lupus erythematosus.
Welch TR; Beischel LS; Balakrishnan K; Quinlan M; West CD
Dis Markers; 1988; 6(4):247-55. PubMed ID: 3266126
[TBL] [Abstract][Full Text] [Related]
17. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
[TBL] [Abstract][Full Text] [Related]
18. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.
Triolo TM; Baschal EE; Armstrong TK; Toews CS; Fain PR; Rewers MJ; Yu L; Miao D; Eisenbarth GS; Gottlieb PA; Barker JM
J Clin Endocrinol Metab; 2009 Nov; 94(11):4517-23. PubMed ID: 19820007
[TBL] [Abstract][Full Text] [Related]
19. Linkage disequilibrium of HLA-DR3 and HLA-DR4 with HLA-B alleles in Mexican patients with rheumatoid arthritis.
Avila-Portillo LM; Vargas-Alarcón G; Andrade F; Alarcón-Segovia D; Granados J
Clin Exp Rheumatol; 1994; 12(5):497-502. PubMed ID: 7842529
[TBL] [Abstract][Full Text] [Related]
20. HLA antigens associated with systemic lupus erythematosus in Japan.
Hashimoto H; Tsuda H; Matsumoto T; Nasu H; Takasaki Y; Shokawa Y; Hirose S; Terasaki PI; Iwaki Y
J Rheumatol; 1985 Oct; 12(5):919-23. PubMed ID: 3878879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
